CVS Health

CVS Health Care Market cap $122B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Apr 1 – Jun 30, 2026 reported Aug 5, 2026

Revenue$106.10B +7% year over year

Gross profit$47.23B 45% margin

Operating profit$4.70B 4% margin

Net profit$2.98B 3% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Segment revenue	121.99	115%
Health services	48.24	46%
Health care benefits	35.97	34%
Pharmacy & consumer wellness	31.99	30%
Other	5.67	5%
Corporate/ other	0.13	0%
Eliminations	−15.90	−15%
Net revenue	106.10	100%	+7%
Cost of revenue	−58.86	55%
Gross profit	47.23	45% margin	−1pp
Operating expenses	−42.53	40%
Operating profit	4.70	4% margin	+2pp
Interest & other costs	−0.74
Tax	−0.98
Net profit	2.98	3% margin	+2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	100.43	100%	+6%
Health services	42.61	42%
Health care benefits	35.48	35%
Pharmacy & consumer wellness	21.75	22%
Other	0.57	1%
Corporate/ other	0.01	0%
Cost of revenue	−55.44	55%
Gross profit	44.98	45% margin	−1pp
Operating expenses	−40.30	40%
Operating profit	4.68	5% margin	+1pp
Interest & other costs	−0.76
Tax	−0.98
Net profit	2.94	3% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	105.7	100%	+8%
Cost of revenue	−59.1	56%
Gross profit	46.6	44% margin	+1pp
Operating expenses	−44.5	42%	+0pp
Operating profit	2.1	2% margin	+0pp
Interest & other costs	−0.7
Tax benefit	1.6
Net profit	2.9	3% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Segment revenue	116.39	118%
Health services	40.12	41%
Health care benefits	35.83	36%
Premiums	34.20	35%
Front store	5.37	5%
Other	0.86	1%
Corporate/ other	0.01	0%
Eliminations	−17.47	−18%
Net revenue	98.92	100%	+8%
Cost of revenue	−54.01	55%
Gross profit	44.91	45% margin	+0pp
Operating expenses	−42.53	43%	+0pp
Operating profit	2.38	2% margin	−1pp
Interest & other costs	−0.73
Tax	−0.63
Net profit	1.02	1% margin	−1pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 31, 2025).
Item	Value	Share of revenue	Year over year
Segment revenue	110.58	117%
Health services	38.10	40%
Health care benefits	34.41	36%
Premiums	32.82	35%
Front store	5.24	6%
Corporate/ other	0.01	0%
Eliminations	−15.99	−17%
Net revenue	94.59	100%	+7%
Cost of revenue	−51.06	54%
Gross profit	43.53	46% margin	+0pp
Operating expenses	−40.16	42%	+0pp
Operating profit	3.37	4% margin	+1pp
Interest & other costs	−0.76
Tax	−0.84
Net profit	1.78	2% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Sep 30, 2024).
Item	Value	Share of revenue	Year over year
Segment revenue	109.48	115%
Health services	40.79	43%
Health care benefits	32.56	34%
Premiums	30.93	32%
Front store	5.20	6%
Corporate/ other	0.01	0%
Eliminations	−14.06	−15%
Net revenue	95.43	100%	+6%
Cost of revenue	−52.95	55%
Gross profit	42.48	45% margin	+5pp
Operating expenses	−41.65	44%	+0pp
Operating profit	0.83	1% margin	−3pp
Interest & other costs	−0.75
Net profit	0.09	0% margin	−2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Apr 1 – Jun 30, 2026 reported Aug 5, 2026 Operating margin 4% Net profit $2.98B	Apr 1 – Jun 30, 2026	Aug 5, 2026	$106.1B	+7%	4%	$2.98B	3%
Q1 FY26 Jan 1 – Mar 31, 2026 reported May 6, 2026 Operating margin 5% Net profit $2.94B	Jan 1 – Mar 31, 2026	May 6, 2026	$100.4B	+6%	5%	$2.94B	3%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 10, 2026 Operating margin 2% Net profit $2.94B	Oct 1 – Dec 31, 2025	Feb 10, 2026	$105.7B	+8%	2%	$2.94B	3%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Jul 31, 2025 Operating margin 2% Net profit $1.02B	Apr 1 – Jun 30, 2025	Jul 31, 2025	$98.9B	+8%	2%	$1.02B	1%
Q1 FY25 Jan 1 – Mar 31, 2025 reported May 1, 2025 Operating margin 4% Net profit $1.78B	Jan 1 – Mar 31, 2025	May 1, 2025	$94.6B	+7%	4%	$1.78B	2%
Q3 FY24 Jul 1 – Sep 30, 2024 reported Nov 6, 2024 Operating margin 1% Net profit $0.09B	Jul 1 – Sep 30, 2024	Nov 6, 2024	$95.4B	+6%	1%	$0.09B	0%